Plantibodies

📍 Paris, France👥 6 employees💰 Last funded Dec 2025
Biotechnology Research
LinkedIn
Plantibodies is a biotech developing a sustainable platform to produce and deliver oral biologics with increased efficacy and less adverse side effects for the patients. Thanks to molecular farming and synthetic biology, our technology enables to produce humanized monoclonal antibodies within edible plant leaves instead of using animal cells, while drastically reducing carbon footprint, slashing production costs by over 90%, and offering medications with remarkable room temperature stability. By effortless storage and a potential worldwide distribution to treat diseases at home such as cancers, inflammations, metabolic diseases and infections, Plantibodies avoids burdensome intravenous injections at hospital while positively impacting lives globally.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in Plantibodies?
Plantibodies has 1 investors on record on gritt.io.
When did Plantibodies last raise funding?
The most recent investment in Plantibodies recorded on gritt.io was in December 2025.
What industry is Plantibodies in?
Plantibodies operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Plantibodies based?
Plantibodies is headquartered in Paris, France.